Together, DSM and Avril will produce a unique protein based on non-genetically modified canola. Its functional properties, high nutritional value, and balanced taste profile, make it ideal for a range of applications including meat and dairy alternatives, beverages, baked products, bars and ready-to-mix, according to the companies.
"With 10 billion inhabitants by 2050, experts predict global demand for both animal and plant-based protein to grow, with exponential growth in plant-based proteins due to dietary shifts. Through this collaboration, Avril and DSM intend to join forces to contribute through innovation to meet the growing demand," said Avril CEO Jean-Philippe Puig.
“More people are opting for flexitarian, vegetarian, and vegan diets for personal, health, and environmental reasons. With our expertise, DSM can support all forms of proteins produced to the highest sustainable standards. With Avril as a partner, we will be uniquely positioned to serve this growing market and look forward to helping our customers deliver great tasting, healthy, and sustainable food and beverages,” added DSM Chief Innovation Officer Trish Malarkey.
The partners’ ambition is to develop a state-of-the-art industrial production facility fully dedicated to canola proteins at Avril’s Saipol facility in Dieppe. Commercial availability from first production could be as early as the end 2021.